{"sourcedb":"DevicePMAs@therightstef","sourceid":"P110001_S000","text":"Approval for the rx herculink elite renal stent system. this device is indicated for use in patients with atherosclerotic disease of the renal arteries following sub-optimal percutaneous transluminal renal angioplasty (ptra) of a de novo or restenotic atherosclerotic lesion (\u003C= 15 mm in length) located within 10 mm of the renal ostium and with a reference vessel diameter of 4.0 - 7.0 mm. suboptimal ptra is defined as \u003E= 50% residual stenosis, \u003E= 20 mmhg peak systolic or \u003E=  10 mmhg mean translesional pressure gradient, flow-limiting dissection, or timi [thrombolysis in myocardial infarction] flow \u003C= 3.","project":"consensus_PMA_Age_Indications"}